Adjuvant Dendritic Cell Immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adjuvant Dendritic Cell Immunotherapy, covering 2024-05-08 to 2024-05-08. Get the full timeline:
Most recent: Clinical Trial Update: Adjuvant Dendritic Cell Immunotherapy for Pediatric Patients With High-grade Glioma or Diffuse Intrinsic Pontine Glioma [Phase 1, Phase 2]